Angelica Cazaly
About Angelica Cazaly
Angelica Cazaly is a Group Leader at Adaptimmune Ltd in Abingdon, UK, specializing in T cell immunology and bioassay development. She has a PhD in Immunology from the University of Southampton and has held various roles in the field since 2015.
Work at Adaptimmune
Angelica Cazaly has been serving as Group Leader at Adaptimmune Ltd since 2018. In this role, she coordinates and oversees assay tech transfers to Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs). Her work involves the development of bioassays to characterize Adaptimmune’s SPEAR® T-cells. She ensures that all processes comply with regulatory standards, including Human Tissue Authority (HTA) regulations, through the production and review of documentation within quality management systems such as Master Control and Laboratory Information Management Systems (LIMS) and Electronic Lab Notebooks (ELN).
Previous Experience at Adaptimmune
Before her current position, Angelica Cazaly worked at Adaptimmune Ltd as an Analytical Development Scientist from 2015 to 2017. During this time, she contributed to the analytical aspects of product development, focusing on the methodologies required for the characterization and validation of therapeutic products. Her experience in this role laid the groundwork for her transition to Group Leader, where she now oversees broader aspects of assay development and compliance.
Education and Expertise
Angelica Cazaly earned her Doctor of Philosophy (PhD) in Immunology from the University of Southampton, where she studied from 1997 to 2001. Prior to this, she obtained a Master of Science (MSc) in Biochemistry and Molecular Biology from Stockholms universitet, studying from 1992 to 1996. Additionally, she completed her secondary education at Thorhildsplans gymnasium in 1991. Her academic background provides a strong foundation for her expertise in T cell immunology and bioassay development.
Research Fellowship Experience
Angelica Cazaly served as a Research Fellow at the University of Southampton from 2009 to 2015. In this capacity, she engaged in advanced research projects, contributing to the scientific community's understanding of immunology. Her experience in this role enhanced her research skills and prepared her for her subsequent positions in the biotechnology sector, including her current role at Adaptimmune.
Scientific Contributions
In her current position, Angelica Cazaly provides scientific input and guidance on bioassay development and qualification to Good Practice (GxP) standards. Her focus on T cell immunology and immune monitoring of clinical trials reflects her commitment to advancing the field and ensuring the efficacy and safety of therapeutic products developed at Adaptimmune.